Jeff Simmons
Chief Executive OfficerElancoPaul Casady
Senior ConsultantBrakke ConsultingMs. Sandra Bruckner
Managing DirectorAstraSana Animal Health AGBrian Kanke
PresidentZoo Pharma DynamicsRoxanne Feller
Secretary GeneralAnimal Health EuropeAaron Schacht
CEOBiomEditAdrienne Woodward
Senior Manager - Discovery & Novel ProductsUnited Animal HealthRob Kelly
Senior Vice President, Commercial Leader for EURAM RegionMSD Animal HealthJan Moehlenbrock
Associate Vice President, Operations EURAMMSD Animal HealthCarel du Marchie Sarvaas
Executive DirectorHealthforAnimals Global Animal Health AssociationCarel du Marchie Sarvaas has been working as a senior government affairs and communications advisor in Brussels and Washington DC for 20 years.
He will move to IFAH from EuropaBio, the Association of Biotechnology Industries, where he has been Director for Agricultural Biotechnology for some 4 years. Prior to EuropaBio, Carel worked at international consultancies and think tanks in Brussels and Washington DC, most often serving clients with science-based policy and communications challenges.
Jürgen Horn
CEOInvetxDr Eve Hanks
Chief Executive Officer & FounderMI:RNA DiagnosticsLouisa Chaves
PrincipalL.E.K ConsultingTodd Richter
Senior Managing DirectorGuggenheim PartnersEllen de Brabander
Executive Vice President R&D and InnovationElancoTobias Hestler
Chief Financial OfficerHaleonJulie Lawless
PresidentLawless Strategic CommunicationsAnshul Krishnan
Business Development AssociateAkston BiosciencesMark Heffernan
Senior VP of Biotherapeutics and CEO of Ceva Biotechnology Campus (Philadelphia)CevaPhil Austin
Managing Partner & Co-FounderAnterra CapitalRon Phillips
Senior Vice President, PolicyAnimal Health InstituteJustine Conway
Vice President of Business Development & External InnovationElancoTim Bettington
Executive Vice President, Corporate Strategy & Market DevelopmentElancoLourdes Mottier
Business Development Head of Strategy & Chief of StaffElancoTom Weaver
Co-Founder, PetMedix & DirectorBlackHawk InnovationSebastian Kusmierczyk
Vice President, Corporate & Global Innovation StrategyElancoJamie Brannan
Executive Vice President and Group President International Operations, Aquaculture and Global DiagnosticsZoetisFabio Paganini
Head, Latin America Region Animal HealthBoehringer IngelheimJoe Harvey
Head of Animal HealthS&P GlobalPierre Ducray
Vice President, Global Technical Development,ElancoSteve Nanchen
Senior Director, External Innovation EU & APAC PacificElancoTom Seaman
Senior Advisor, Business DevelopmentElancoMatthias Hofer
Managing PartnerSC GroupMatthias Hofer is the Managing Partner at Stonehaven Consulting AG with over 15 years of experience in Animal Health. He served on the executive committees of two major Animal Health companies for a total of 7 years. Between 2009 and 2013 he led the global Aqua Health business at Novartis Animal Health (NAH). Later on, he was Global Leader Emerging Business at Elanco and a member of Elanco’s global executive committee. During 2014 and with Elanco’s intention to buy NAH, Matthias served as overall pre-merger integration leader on the Novartis side. In that role, Matthias led a large team and efforts to prepare integration pre-closing overall including carve-out preparations of operations linked to Novartis.
Adrian Grosu
Partner, SC AnalyticsSC GroupBeatrice Vos, PhD
PartnerStonehaven Cozmix Group (and CEO @ SC Transactions AG)Michael Fitzke
Senior Director AI, Next Generation TechnologiesMars Science & DiagnosticsEmmanuelle Soubeyran
Director GeneralWorld Organisation for Animal HealthAlan Mackay
Executive Partner and FounderGHO CapitalJesper Nordengaard
CEODechraBrandon Vasquez
Research Analyst, HealthcareWilliam BlairDave Westenberg
Managing Director Equity ResearchPiper SandlerNavann Ty
Lead Analyst for HealthcareBNP Paribas